Evaluation of the pharmacokinetics, pharmacodynamics and safety of repeated escalating oral doses of a slow release formulation of S 38844 in healthy male volunteers An open-label, non-randomised, two-group three-period, monocentre study

Trial Profile

Evaluation of the pharmacokinetics, pharmacodynamics and safety of repeated escalating oral doses of a slow release formulation of S 38844 in healthy male volunteers An open-label, non-randomised, two-group three-period, monocentre study

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs S 38844 (Primary)
  • Indications Cardiovascular disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 24 Oct 2012 Actual end date (12 Aug 2011) added as reported by European Clinical Trials Database.
    • 24 Oct 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 14 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top